Company: Teragenix Corporation

Headquarters Address: 5440 NW 33rd Avenue
Suite 108
Fort Lauderdale, FL 33309

Main Telephone: (954) 343-0180

Website: http://www.----Publisher Mary
Ann Liebert, Inc.liebertpub.com) will provide free online access
to all issues of its authoritative, peer-reviewed publication Journal
of Women's Health for the entire month of May in recognition of
National Women's Health Week, May 8-14, 2005.liebertpub . A
complete list of the firm's 60 journals, books and newsmagazines is
available at www.

health disorders

Cell therapy technologies overlap with those of gene therapy,
cancer vaccines, drug delivery, tissue engineering and regenerative
medicine.
Sources of cells, both human and animal (xenotransplantation) are
discussed .
Collectively, the value of the cell-based markets is estimated to
be $26.com

Type of Organization: Private

Industry: Health: Research + Science

Key Executives: President: Joseph Mauro
VP-Business Development: Valentin Adia, Jr.

Business Editors/Biotech Writers
BIOWIRE2K

NEW ROCHELLE, N. (www."
Mary Ann Liebert, Inc.

disorders top

Research and Markets: Value of Cell-based Therapies Market Estimated to Reach $26.6 billion in 2005 with Largest Expansion in Diseases of Central Nervous Syst

Business Editors/Health/Medical Writers/Health Editors/Medical
Editors

DUBLIN, Ireland----Research and
Markets (http://www.researchandmarkets .com/reports/c10806) has
announced the addition of Cell Therapy - Technologies, Markets and
Companies to their offering
This report describes and evaluates cell therapy technologies and
methods, which have already started to play an important role in the
practice of medicine.
Safety is an essential consideration of any new therapy and regulatory
considerations for cell therapy are those for biological preparations. Of these, 84 are involved in stem
cell therapy.com/reports/c10806

com

Public Relations
Contact: Joseph Mauro
Phone: (954) 343-0180 x303
Email: jlmauro@teragenix.com

,
publishers.

diseases xeroderma

Some light is
thrown on the current controversy of embryonic sources of stem cells
and comparison with adult sources.

Various types of cells used, methods of preparation and
culture, encapsulation and genetic engineering of cells are discussed. Methods of delivery of cell therapy range from injections
to surgical implantation using special devices.researchandmarkets.com

Customer Service
Contact: John Gressard
Phone: (954) 343-0180 x302
Email: jgressard@teragenix .

Journal of Women's Health Available Free Online in Honor of Women's Health Week

health top

Cell therapy is
bound to become a part of medical practice.
Cell therapy has applications in a large number of disorders.2 billion in 2010, and $96. Skin and soft tissue repair as well as diabetes
mellitus will be other major markets. More than 300 companies have
been identified to be involved in cell therapy and 183 of these are
profiled in part II of the report. TGC offers clinical trial management
services , biological materials, quality control products, central
laboratory testing and other solutions that enable product development
and research in infectious diseases, oncology, rheumatology,
endocrinology , cardiology and genetic disorders. The Journal covers the latest advances
and clinical applications of new diagnostic procedures and therapeutic
protocols for the prevention and management of women 's healthcare
issues., is a privately held, fully integrated
media company known for establishing authoritative peer-reviewed
journals in many promising areas of science and biomedical research
including Obesity Management, Thyroid, Metabolic Syndrome and Related
Disorders, and Diabetes Technology and Therapeutics. Its biotechnology
trade magazine, Genetic Engineering News (GEN), was the first in its
field and is today the industry's most widely publication worldwide.

xeroderma conditions

The
most important are diseases of the nervous system and cancer which are
the topics for separate chapters. Other applications include cardiac
disorders (myocardial infarction and heart failure), diabetes
mellitus, diseases of bones and joints, genetic disorders, and wounds
of the skin and soft tissues.3 billion in
2015 .

Company Profile for Teragenix Corporation

Teragenix provides products and services
that support research and development activities and accelerates the
time to market of products.liebertpub.

genetic diseases

Stem cells are discussed in detail in one chapter. Stem cells can also be genetically modified prior to
transplantation . Important collaborations in the area of cell therapy are
shown.
VP-Sales + Marketing: John Gressard

Investor Relations
Contact: Valentin Adia, Jr.
"Journal of Women's Health is the primary source of information
that meets the challenge of providing optimum healthcare for women,"
says Mary Ann Liebert, President and CEO of Mary Ann Liebert, Inc .

pigmentosum x

Current political debate on the
use of stem cells from embryonic sources (hESCs) is also presented .6 billion in 2005, $56. The largest expansion will be in diseases of the central nervous
system and cancer.
For more information visit
http://www.

Business Editors

----Teragenix Corporation (TGC) is a trusted
partner in the development of in vitro diagnostic (IVD) and
biopharmaceutical products.teragenix. To obtain free access to
the full text of the Journal, visit www.com/jwh
Journal of Women's Health is a core multidisciplinary journal
dedicated to the diseases and conditions that hold greater risk for or
are more prevalent among women.

pigmentosum top

Hematopoietic stem cell transplantation is
replacing the old fashioned bone marrow transplants. Other sources of stem cells such as
the placenta, cord blood and fat removed by liposuction are also
discussed.
Regulatory and ethical issues involving cell therapy are important
and are discussed. Ethical issues concern mainly use of fetal tissues
and xenografts from nonhuman primates.
The number of companies involved in cell therapy has increased
remarkably during the past few years.
Phone: (954) 343 -0180 x304
Email: vadia@teragenix. "I am happy to provide access to the latest management
strategies and cutting-edge research published in the Journal.com